DIN 00498335 — PHENYTOIN SODIUM INJECTION USP 50 MG
PHENYTOIN SODIUM INJECTION USP is a solution of Phenytoin marketed by JUNO PHARMA CANADA INC.. The full Phenytoin monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 00498335
- Brand name
- PHENYTOIN SODIUM INJECTION USP
- Active ingredient
- Phenytoin
- Strength
- 50 MG
- Dosage form
- SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Manufacturer
- JUNO PHARMA CANADA INC.
- Health Canada status
- DORMANT
- Drug class
- Hydantoin anticonvulsant
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Phenytoin products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 00022780 | DILANTIN | 100 MG | CAPSULE | BGP PHARMA ULC | MARKETED |
| 00022772 | DILANTIN | 30 MG | CAPSULE | BGP PHARMA ULC | MARKETED |
| 00023698 | DILANTIN INFATABS | 50 MG | TABLET (CHEWABLE) | BGP PHARMA ULC | MARKETED |
| 02460912 | PHENYTOIN SODIUM | 100 MG | CAPSULE | AA PHARMA INC | MARKETED |
| 00780626 | PHENYTOIN SODIUM INJECTION USP | 50 MG | LIQUID | SANDOZ CANADA INCORPORATED | MARKETED |
| 02431378 | PHENYTOIN SODIUM INJECTION USP | 50 MG | SOLUTION | HIKMA CANADA LIMITED | MARKETED |
| 02250896 | TARO-PHENYTOIN | 125 MG | SUSPENSION | TARO PHARMACEUTICALS INC | MARKETED |